Unintended reporting of misleading Hb A(1c) values when using assays incapable of detecting hemoglobin variants.

Arch Pathol Lab Med

From the Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia (Drs Rhea, Koch, Ritchie, Young, and Molinaro); the Department of Pathology and Laboratory Medicine, Grady Memorial Hospital, Atlanta, Georgia (Drs Koch and Young); the Department of Pathology, Hindu Rao Hospital, New Delhi, India (Dr Singh); and Laboratory Medicine, Quest Diagnostics, Atlanta, Georgia (Dr Burgess).

Published: December 2013

Context: It is recommended that hemoglobin (Hb) A1c (Hb A1c) not be used to assess average glycemia in patients who have altered red blood cell life span.

Objective: To investigate the frequency of reporting an Hb A1c value for Hb variant samples that do not include Hb A.

Design: Hb A1c samples (n = 500) were procured and screened for Hb variants that may affect Hb A1c interpretation (Hb SS, Hb SC, and Hb S-β-thalassemia). Five of each of these samples were tested by ion-exchange high-performance liquid chromatography, immunoturbidimetric assay, second-generation immunoturbidimetric assay, and affinity chromatography.

Results: Eleven (2.2%) homozygous Hb SS, 6 (1.2%) Hb SC, and 5 (1.0%) Hb S-β-thalassemia samples were identified out of the 500 samples tested. Three of 4 instruments investigated in this study are known to not be plagued by analytic interference from these Hb variants but disturbingly reported Hb A1c values in the absence of Hb A.

Conclusions: The improved analytic specificity of Hb A1c platforms has by and large eliminated interferences from the most common heterozygous Hb variants. A consequence, however, is the potential for unintended reporting of Hb A1c results in the presence of homozygous and compound heterozygous Hb variants that lack Hb A and the inability to distinguish those samples not recommended to be used for patient care. The ability to identify samples harboring Hb variants that preclude the utility of Hb A1c may be beneficial in high prevalence populations.

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2012-0714-OADOI Listing

Publication Analysis

Top Keywords

a1c
10
unintended reporting
8
a1c values
8
reporting a1c
8
s-β-thalassemia samples
8
samples tested
8
immunoturbidimetric assay
8
heterozygous variants
8
samples
7
variants
6

Similar Publications

Introduction: Neighborhood disadvantage may be an important determinant of cardiometabolic health and cognitive aging. However, less is known about relationships among individuals with mild cognitive impairment (MCI).

Methods: The objective of this study is to investigate the relationship between neighborhood disadvantage measured by national Area Deprivation Index (ADI) rank with measures of cardiometabolic health and cognition among Wake Forest (WF) Alzheimer's Disease Research Center (ADRC) participants, with and without MCI.

View Article and Find Full Text PDF

Abnormalities of carbohydrate antigen 19 - 9 (CA19-9) are common in patients with type 2 diabetes mellitus (T2DM), and in some patients, CA19-9 returns to normal level after glycemic control. The aim of this study was to investigate the factors associated with CA19-9 levels in patients with T2DM and the associated influences on the degree of reduction of CA19-9 levels after antidiabetic therapy (AT). This study was an observational cross-sectional study.

View Article and Find Full Text PDF

Type 2 Diabetes Disease and Management Patterns Across a Large, Diverse Healthcare System: Issues and Opportunities for Guideline-Directed Therapies.

Am Heart J

January 2025

Accelerator for Clinical Transformation, Brigham and Women's Hospital, Boston, MA; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

Background: The prevalence, chronicity and clinical impact of type 2 diabetes (T2D) defines this disease state as a critical determinant in morbidity and mortality, as encountered by individuals, health care systems, and public health in general. The need to understand and optimize T2D identification and management is now further heightened by the advent of medications with established cardiovascular (CV) and kidney benefits in such patients, namely sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1 RA). Prescription rates for these agents have remained low despite guidelines incorporating and emphasizing their use.

View Article and Find Full Text PDF

We developed and validated a surgical technique to measure central venous pressure (CVP) in Nile tilapia, and investigated the effects of an acute temperature decrease (from 30 vs. 24 °C) and changes in heart rate (f) using zatebradine hydrocholoride, which decreases intrinsic f on this species' cardiac function. As predicted, f and cardiac output ( ) were ~ 40% lower in the acutely cooled fish, and both groups had very comparable (i.

View Article and Find Full Text PDF

[Diabetes mellitus and total joint arthroplasty-What should be considered?].

Orthopadie (Heidelb)

January 2025

ECOM - Praxis für Orthopädie, Sportmedizin und Unfallchirurgie, München, Deutschland.

Diabetes mellitus (DM) is on the rise in the population. Approximately 10% of adults suffer from DM. Over two-thirds of patients are over 60 years old, and thus it particularly affects patients who have to undergo total joint arthroplasty.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!